PFIZER INC, 10% Owner, added 50,000 shares of Pfizer Inc. (PFE) to its portfolio at the rate of $17.00 per share valuing $850,000 on May 13. The insider has now 3,249,973 shares of the company to its portfolio. Before making a move on any particular stock, readers often pay close attention to support and resistance markers. The last reported price for shares of Pfizer Inc. (PFE) was $42.50. Currently, the 1st Resistance Point for this stock is $42.97, with a 2nd Resistance Point sitting at $43.44. Meanwhile, this company’s stock has a 1st Support Level at $42.20 and a 2nd Support Level at $41.89. Pfizer Inc. (PFE) stock has lost -$0.21, or -0.49%, in the past five days. In the last full month, these shares have gained $1.93, or 4.76%. In the past three months, this stock’s price has risen by $0.49, or 1.17%. This year-to-date, Pfizer Inc. (PFE) shares have lost -$1.15, or -2.63%.
Analyzing price projection indicators is a helpful way to determine whether a potential stock buy is a wise choice for profits in the short term, medium term, and long term. For Pfizer Inc. (PFE) stock, 60% of short-term indicators suggest that these shares are a “ Buy .” Meanwhile, 50% of medium-term indicators point to this stock being a “ Buy .” Looking further ahead, 0% of long-term indicators suggest that this stock is a “ Hold .”
With 5,559,929 K shares outstanding, this company currently has a market capitalization of $239,521,760K. Pfizer Inc. (PFE) generates $53,647 M in annual sales, amounting to annual net income of $11,152 M. This stock has generated a 1-Year Total Return of 17.34%, a 3-Year Total Return of 24.20%, and a 5-year Total Return of 42.71%. This stock’s 5-Year Dividend Growth is 41.67%, with its most recent dividend valued at $0.360 per share on 05/09/19. Its Annual Dividend Yield is 3.37%, and its Annual Dividend Rate is 1.44.
In the most recently-reported fiscal quarter, which ended in Mar-19, Pfizer Inc. (PFE) reported earnings of $0.85 per share. Wall Street analysts, on average, were expecting the company to report earnings of $0.75 per share, representing a 0.1 difference and 13.14% surprise. In the previous quarter ending in Dec-18, the reported earnings of $0.64 represented a 0.01 difference from the consensus estimate calling for $0.63 per share, which was a 1.19% surprise.
For the current fiscal quarter, which is set to end in 06/2019, the average earnings estimate is $0.78 per share. This estimate came from a total of 4 Wall Street Analysts. Of those market experts, the high estimate was $0.81 and the low estimate was $0.76. In the year-ago quarter, Pfizer Inc. (PFE) generated per-share earnings of $0.81. If the analysts are correct about the current quarter’s earnings, the growth will be -3.70% .
Turning our focus now to insider trading activity, there have been 0 purchases (0 shares in total) and 25 sale (27,955 shares in total) in the last 3 months. In the last 6 months, there have been 42 insider buys amounting to 2,611,359 shares and 227 insider sales amounting to 2,661,460 shares. In the past full year, 48 insider purchases were made (involving 3,893,272 shares) and 286 insider sell-offs equivalent to 3,441,888 shares.
Moving onto liquidity, Pfizer Inc. (PFE) has a Current Ratio of 1.57, a Quick Ratio of 1.33 and a Cash Ratio of 0.59. Looking at this company’s capital structure, its Total Debt to Total Equity is 65.83, its Total Debt to Total Capital is 39.70, and its Total Debt to Total Assets is now 26.18. Looking even further ahead into the future, its Long-Term Debt to Equity is 51.92 and its Long-Term Debt to Total Capital is 31.30.